Being Alive; November 1997
The focus of the session was the correlation of clinical outcomes with various levels of HIV suppression. Dr. Schlomo Staszewski of J.W. Goethe University in Frankfurt studied data on 1593 HIV+ patients participating in six trials of various therapies.
Of the 195 patients who developed AIDS within one year, 188 (96%) did not have a reduction in viral load to less than 5,000 copies/mL. On the other hand, among the 323 individuals who sustained a viral load of less than 5,000, only 7 (2%) had an AIDS defining event. "The HIV RNA level required to prevent progression to AIDS," Dr. Staszewski concluded, "may be higher than that required to delay the emergence of drug resistance."
When asked if this meant that untreated HIV+ patients with viral loads below 5,000 may not require treatment, Dr. Staszewski could not concur. "We are not talking about natural history here," he said. "The aim of treatment is still clearly to reduce RNA to undetectable levels."
Reprinted from We The People with HIV/AIDS of the Delaware Valley
971101
BA971112
Copyright © 1997 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/